CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Grant or award Director acquired 32,428 shares (grant or award)
- 4 Planned sale PRINCIPAL ACCOUNTING OFFICER sold 4,000 shares at an average $22.50 ($90,000)
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 2,000 shares at $25.00 ($50,000)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,327 shares at $14.60 ($19,374)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,498 shares at $14.60 ($51,071)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 2,708 shares at $14.82 ($40,133)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,028 shares at $14.82 ($15,235)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,095 shares at $17.05 ($18,670)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,171 shares at $17.05 ($54,066)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,919 shares at $18.23 ($89,673)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 475 shares at $19.96 ($9,481)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 773 shares at $19.96 ($15,429)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 3 of 35 · 686 filings